Nemaura Medical Announced That The Nasdaq Hearings Panel Granted The Company's Request For Continued Listing Under An Exception, Which Ultimately Expires On April 1 2024 - 8K
Nemaura Medical Announced That The Nasdaq Hearings Panel Granted The Company's Request For Continued Listing Under An Exception, Which Ultimately Expires On April 1 2024 - 8K
Nemaura Medical宣布，纳斯达克听证会小组在例外情况下批准了该公司继续上市的请求，该请求最终将于2024年4月1日到期-8K
Nemaura Medical Announced That The Nasdaq Hearings Panel Granted The Company's Request For Continued Listing Under An Exception, Which Ultimately Expires On April 1 2024 - 8K
Nemaura Medical宣布，纳斯达克听证会小组在例外情况下批准了该公司继续上市的请求，该请求最终将于2024年4月1日到期-8K